- our experts
- Student Sphere
- Hotel & Travel
Pharmaceutical biotechnology is a field that applies biotechnology techniques to the development, manufacturing, and regulation of drugs. It involves the use of living systems and biological processes to create and modify drugs and biologics, such as vaccines, gene therapies, and monoclonal antibodies.
Pharmaceutical biotechnology encompasses several areas, including:
Recombinant DNA Technology: This involves the use of genetic engineering techniques to modify the DNA of cells to produce proteins with therapeutic properties. This has led to the development of biologics, such as insulin, growth hormones, and monoclonal antibodies.
Cell Culture Technology: This involves the use of cells to produce therapeutic proteins, including the use of recombinant DNA technology to modify cells to produce specific proteins.
Protein Engineering: This involves the modification of proteins to improve their efficacy, stability, and pharmacokinetics, and to reduce their immunogenicity. This can include the use of genetic engineering techniques to modify protein structures and the use of chemical modifications to alter protein properties.
Genomics and Proteomics: This involves the use of high-throughput techniques to identify new drug targets and biomarkers, and to understand the mechanisms of disease and drug action.
Regulatory Affairs: This involves the development of regulatory strategies to ensure the safety and efficacy of biologic drugs, including the evaluation of preclinical and clinical data, and the development of manufacturing and quality control procedures.
Pharmaceutical biotechnology has revolutionized the pharmaceutical industry, leading to the development of several life-saving drugs and biologics. It has also led to the development of personalized medicine, where drugs are tailored to individual patients based on their genetic makeup and disease characteristics. However, the development and manufacturing of biologics can be challenging due to the complexity of these molecules and the need for specialized manufacturing processes and quality control procedures.
The global pharmaceutical biotechnology market is a rapidly growing industry that involves the use of biotechnology techniques in the development and production of pharmaceuticals. This market includes various products and services related to biologics, vaccines, gene therapies, and cell therapies, among others.
According to a report by Grand View Research, Inc., the global pharmaceutical biotechnology market size was valued at USD 328.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. The increasing demand for biologics, rising prevalence of chronic diseases, and growing investments in research and development are driving market growth.
The market is segmented based on product, technology, application, and region. Based on product, the market is segmented into monoclonal antibodies, vaccines, recombinant proteins, cell therapy, gene therapy, and other products. Based on technology, the market is segmented into DNA sequencing, fermentation, cell culture, and other technologies. Based on application, the market is segmented into oncology, infectious diseases, cardiovascular diseases, and other applications.
North America dominated the global pharmaceutical biotechnology market in 2020, followed by Europe and the Asia Pacific. The dominance of North America is attributed to the presence of major pharmaceutical and biotechnology companies, well-established healthcare infrastructure, and increasing investment in research and development activities.
The key players operating in the global pharmaceutical biotechnology market include F. Hoffmann-La Roche Ltd, Amgen Inc., Sanofi, Johnson & Johnson, and Pfizer Inc., among others.
Overall, the pharmaceutical biotechnology market is expected to experience significant growth in the coming years, driven by technological advancements, increasing demand for biologics, and the rising prevalence of chronic diseases.
ALSO READ Drugs and Drug Targets Drug Discovery, Design and Development Pharmacokinetics and Pharmacodynamics Computer Aided Drug Design Drug Metabolism Pharmaceutical Biotechnology Combinatorial Chemistry Novel Drug Delivery Systems Formulations Natural Products Traditional Medicine Drug Repurposing and Drug Repositioning Precision Medicine Personalized Therapies Drug Development and Clinical Trials Biomarker Discovery and Development Biologics and Biosimilars Vaccines and Immunotherapies Steam Cells and Regenerative Medicine Drug Safety and Pharmacovigilance Pharmacogenomics Toxicology Rare Diseases Receptors as Target for Drug Discovery Drugs Affecting the Cardiovascular System Drugs Affecting the Central Nervous System Drugs Affecting Hormonal Systems Chemotherapeutic Agents Antibacterial Agents Antiviral Agents Anticancer Agents The Opioid Analgesics Anti-Ulcer Agents Non-Steroidal Anti Inflammatory Drugs Steroids Antibiotics Antineoplastic Agents Anthelmintics Sulphonamides Artificial Intelligence and Machine Learning in Drug Discovery and Development Genomics and Proteomics in Drug Discovery and Development Gene Therapy and Genome Editing in Treating Genetic Diseases Nanotechnology in Drug Delivery and Imaging Virtual and Augmented Reality in Drug Discovery and Development Patient Engagement and Patient-Centered Drug Development Big Data Analytics in Drug Discovery and Development
Medicinal Chemistry Conferences 2023 Europe Pharmacology Conferences Medicinal Chemistry Conferences 2023 USA Traditional Medicine Conferences Natural Products Conferences Pharmaceutical Chemistry Conferences Combinatorial Chemistry Conferences Precision Medicine Conferences Medicinal Chemistry Conferences 2023 Middle East Medicinal Chemistry Conferences 2023